Pure Blue Tech Inc. (PBT) is developing two patented technologies that are used to create filtration membranes with more resistance to fouling during microfiltration, ultrafiltration, nanofiltration, and reverse osmosis liquid separation processes. This is intended to increase the lifespan of the membranes, reducing maintenance downtime and costs associated with fouled membrane replacement. Rockies Venture Club initially invested in PBT in 2022 alongside multiple syndicate partners. Fast forward to today, PBT is raising a $1M convertible note (20% discount, 7% interest, $16M valuation cap) after making significant progress (detailed below).  This opportunity is open to all RVC investor members.  Join Rockies Venture Club for the Pure Blue Tech Investor Update to learn more about the companies progress, meet the executive team, and discuss the opportunity alongside existing RVC investors. The Investor Update will take place virtually and will cover all the major due diligence questions such as IP, competition, leadership, funding strategy, exit strategy, use of funds, milestones, etc.

Review the Pure Blue Tech Investor Deal Page

July 2024 Update:

Successful Pilot: Pure Blue Tech's highly efficient membrane elements are being operated by U.S. Bureau of Reclamation's Yuma Desalting Plant operators. On the first attempt, PBT's ultrasonic reverse osmosis (USRO) product prevented differential pressure rise 57% better than the control and sustained flux/output (reducing fouling rate) 50% better than the control. With this excellent pilot result, PBT will adjust acoustic intensity and waveform to further mitigate fouling and scaling.

Secured Contracts: PBT has secured a $300K U.S. Bureau of Reclamation performance contract and $200K WA Department of Commerce grant contract. Of this $500K, PBT has received $350K and completed 60% of the USBR project.

Product Market Fit: Pure Blue Tech is now an approved vendor of one of the largest semiconductor manufacturers. With a successful evaluation, PBT's technology would then be considered their "Standard of Record," leading to implementation plant-wide of about 3,000+ units and, in parallel, selling to their other 5 major fabrication facilities worldwide, totaling more than 15,000 membrane elements. PBT is also working to close a PO for 60 units for a full-scale demonstration for a large industrial wastewater treatment and reuse facility in LA County. We expect the PO in Q3 and plan to deliver product in Q4.  These two customers alone use more than $25M of membrane, and are both impressed with PBT's performance data.

Finance and Fundraising: PBT nearly broke even in Q1 2024, with a line of sight for $600k+ in revenue for FY 2024. PBT is forecasting $6-9M in revenue (reaching profitability) in 2026. PBT is currently fundraising via Convertible Note (20% discount, 7% interest, $16M valuation cap) approaching the $7M Series A.  The funds will allow PBT to sell and market their product, hire two top tier production leaders, expand our production team, and purchase raw materials to produce and fulfill orders to customers.

The format for the Deep Dive will be as follows:

Company Long-Form Pitch & Q&A w/ Investors (60 Minutes)

Optional - Investor Only Discussion (30 Minutes)